Clinical Trial Update: A Thorough Corrected QT Interval Trial [Phase 1]

View source ↗

Summary

Phase 1 trial update reporting results from a corrected QT interval safety study conducted in dyslipidemia. The study status is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dyslipidemia

Snippet

Sponsor: Kowa Research Institute, Inc. | Conditions: Dyslipidemia | Phase 1 | Status: COMPLETED